Supreme Court Proposes 16% Margin Cap on Cancer Drugs

The Supreme Court has flagged a 10-fold markup on cancer medications and is seeking to implement a uniform 16% profit margin.

Editor's note: The article accurately reflects the provided source summary.

This article is AI-generated and fact-gated. Original reporting: India Today